Home›Companies›Biotech & Pharma›Proximity Therapeutics

Proximity Therapeutics, Inc.

Updated Oct 27, 2026·Latest SEC filing Jan 4, 2023·Suggest an edit

About Proximity Therapeutics

Proximity Therapeutics is a private company based in Cambridge, Massachusetts, incorporated in 2021 in Delaware. It has reported $11,000,001 raised in one offering on Form D since May 2021. Its chief executive is Guillermo Elias.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
May 4, 2021May 19, 2021amended Jan 4, 2023$11,000,001fully sold9$1.2MEquityRule 506(b)Form D/A ↗1 earlier filing

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on Proximity Therapeutics's Form D filed Jan 4, 2023.

GE
Guillermo Elias
CEO & President
JK
ST
Steven Tregay
Executive officer, director and promoter

Sources

  1. SECPROXIMITY THERAPEUTICS, INC. Form D, filed May 19, 2021
  2. SECPROXIMITY THERAPEUTICS, INC. filing history